Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung Ev |
| Country | Germany |
| Start Date | Jan 01, 2025 |
| End Date | Dec 31, 2029 |
| Duration | 1,825 days |
| Number of Grantees | 26 |
| Roles | Participant; Associated Partner; Coordinator; Third Party |
| Data Source | European Commission |
| Grant ID | 101136376 |
Non-Communicable Diseases (NCDs) e.g. osteoporosis, osteoarthritis, joint & ligament wear, frailty fractures and associated complications in elderly are a severe threat frequently leading to a permanent decline of the patients general health and autonomy. NCD prevention is highly relevant to reduce the need for long-term care.
The economic burden is expected to increase by 65% from 2020 to 2040 with a strong negative impact on patients quality of life.
SmILE will provide a cross-sectoral, early risk detection methodology by holistic analysis of elderly patients health data.
Co-creation with end-users and consideration of diverse needs, mental and physical abilities, living and socio-economic conditions as well as life-situation of older people are implemented. This includes training and enhanced stream of information to patients and other stakeholders.
It will offer an AI-based patient analysis, incl. integration of smart wearables and medical devices incl. implants to support monitoring of general health status. Our approach will disrupt the cycle of frailty by minimizing physical decline and risk of re-fractures.
To enhance the AI functions, new data sources will be established by instrumenting medical devices, mainly implants, to augment them into monitoring and actively supporting devices.
SMILE will: (1) develop an integrated platform to collect, centralize, manage, analyze and share multimorbid geriatric patient data using technology such as AI & machine learning; (2) establish a pan-European bottom-up model of good governance of health data being patient-centered and patient-controlled in line with current regulations; and (3) establish a solution driven by the needs of citizens and patients of old age.
SMILE will establish a new approach of outcome-monitoring to provide patient centered, personalized and integrated treatment of elderly NCD patients to improve quality of life, enable real empowerment and ease the financial burden in an ageing society.
Oncare Gmbh; Innoproof Gmbh; Luxembourg Institute of Health; Csem Centre Suisse D'Electronique Et de Microtechnique Sa - Recherche Et Developpement; Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung Ev; Interuniversitair Micro-Electronica Centrum; Universitatsklinikum Schleswig-Holstein; Eurice European Research and Project Office Gmbh; Bosch Sensortec Gmbh; Betthera Sro; Bg Klinikum Hamburg Ggmbh; Minds & Sparks Gmbh; Swemac Innovation Ab; Universitatsmedizin Rostock; Robert Bosch Aktiebolag; Research and Innovation Services Doo Za Usluge; Swemac Innovation (Germany) Gmbh; Aesculap Ag; Universitaet Rostock; Fundacio Eurecat; Associacao Fraunhofer Portugal Research; Universitaet Zu Luebeck; Consorcio Centro de Investigacion Biomedica En Red M.P.; Universita Degli Studi Di Brescia; Zema - Zentrum Fur Mechatronik Undautomatisierungstechnik Gemeinnutzige Gmbh; Universitat Des Saarlandes
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant